Apollo Hospitals (NSE: APOLLOHOSP) stock is rising amid the raging turmoil of the market. Apollo Hospitals Enterprise’s share price increased by more than 6 percent in trading in the morning on Thursday to its one-year high.
Apollo had reported second-quarter results after market close on Wednesday, which have been better than analysts’ expectations.
Apollo Hospitals Enterprise stock opened at Rs 7260.00 on BSE on Thursday, up more than 4% from its previous close.
After this, Apollo Hospitals Enterprise’s share price reached an intraday high of Rs 7435.40, which is its 52-week high.
How Were Apollo’s Results?
According to a report, Apollo Hospitals reported a 15% year-on-year growth in its consolidated revenue in the second quarter, jumping to Rs 5,589 crore.
EBITDA (earnings before interest, tax, depreciation, and amortization) rose 30 percent YoY to 816 crore rupees.
Strong growth in operating profit was driven by a slightly lower tax rate and reported second-quarter consolidated net profit grew 63% YoY to ₹379 crore.
Apollo Enterprises’ EBITDA margin at 14.6% came in better than 13.3% in the previous quarter and 12.9% in the year-ago quarter.
Notably the margin was the highest in at least the last 5 quarters.
A renowned brokerage stated that its EBITDA margin increased by 160bp YoY to 14.6 percent, compared to its forecast of 14.1 percent due to lower employees and other expenses.
The company’s net profit stood at ₹379 crore, better than Motilal’s estimate of ₹361 crore.
Healthcare Services Q2 FY25 performance also remained strong, with revenues growing 14% YoY.
The segment’s EBITDA margin remained strong at 24.8%, leading to a 16% YoY growth in segment net profit.
Average Revenue Per Operating Bed (ARPOB) also grew 3% YoY to ₹59,011 in the quarter. The number of patients treated grew 8% for the second quarter.
Quick Fact
| Company name | Apollo Hospitals |
|---|---|
| Revenue growth | 15% YoY |
| Revenue | ₹5,589 crore |
| EBITDA growth | 30% YoY |
| EBITDA | ₹816 crore |
| EBITDA margin | 14.6% |
| Previous EBITDA margin | 13.3% |
| Year-ago EBITDA margin | 12.9% |
| Margin increase | 160 basis points YoY |
| Net profit growth | 63% YoY |
| Net profit | ₹379 crore |
| Estimated net profit | ₹361 crore |
| Healthcare revenue growth | 14% YoY |
| Healthcare EBITDA margin | 24.8% |
| Healthcare net profit growth | 16% YoY |
| ARPOB growth | 3% YoY |
| ARPOB | ₹59,011 |
| Patient growth | 8% |
Disclaimer: The website and its content are for informational purposes only and should not be considered investment advice.
